BRIAN T GRIFFIN
CIK 1252006 · Chairman and CEO · last filed 2021-04-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$132.4K
Companies
5
Total Filings
38
Lifetime Open-Market Net
-$55.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRH Medical Corp (CRHM) Delisted | Director | — | $3.99 | — | $0 | 2 | 2020-06-15 |
| Diplomat Pharmacy, Inc. (DPLO) Delisted | Chairman and CEO | 0 | — | — | $0 | 4 | 2020-02-10 |
| Elevance Health, Inc. (ANTM) Delisted | EVP & CEO, IngenioRx | 38,554 | $482.58 | $18.61M | -$13.33M | 1 | 2018-05-07 |
| ANTX | EVP & President, CSBD | 28,168 | $4.70 | $132.4K | $0 | 10 | 2018-03-05 |
| MEDCO HEALTH SOLUTIONS INC (MHS) Delisted | President, International | 0 | — | — | -$42.59M | 20 | 2012-04-03 |
Recent Filings · Page 2 of 4
38 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-04-05 | ANTX | Tax (F) | −2,356 | -$392.3K | EDGAR |
| 2017-03-07 | ANTX | Tax (F) | −1,963 | -$325.9K | EDGAR |
| 2017-03-03 | ANTX | Mixed | +3,948 | -$153.2K | EDGAR |
| 2016-08-05 | ANTX | Tax (F) | −213 | -$27.2K | EDGAR |
| 2016-04-05 | ANTX | Tax (F) | −2,356 | -$334.2K | EDGAR |
| 2016-03-04 | ANTX | Tax (F) | −2,475 | -$329.1K | EDGAR |
| 2016-03-03 | ANTX | Mixed | +1,694 | -$527.5K | EDGAR |
| 2016-02-03 | ANTX | Tax (F) | −2,655 | -$344.4K | EDGAR |
| 2012-04-03 | MEDCO HEALTH SOLUTIONS INC (MHS) Delisted | Disp (D) | −112,825 | $0 | EDGAR |
| 2012-02-28 | MEDCO HEALTH SOLUTIONS INC (MHS) Delisted | Mixed | +6,119 | -$447.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.